Vertex appoints Kewalramani as CEO

Vertex Pharmaceuticals has named Reshma Kewalramani as president and CEO, effective April 1, 2020. She will replace Jeffrey Leiden in the roles as he transitions to executive chairman. Kewalramani was previously chief medical officer and EVP of global medicines development and medical affairs. 

GSK names Symonds non-executive chair 

GlaxoSmithKline has appointed Jonathan Symonds as non-executive chairman of its board, effective September 1. He will succeed Philip Hampton in the position. Symonds is currently deputy group chairman of HSBC and a former CFO of Novartis and AstraZeneca.

Ashfield hires Esgro 

Ashfield has appointed George Esgro as president of global business development for Ashfield Commercial and Patient Solutions. He was most recently VP of strategic business development for U.S. commercial at Iqvia. 

Client-side people moves courtesy of MM&M sister brand The PMD.

The Escalator is a weekly roundup of notable people moves in the pharmaceutical and healthcare marketing industries. For submissions, email Frank Washkuch at